alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › plasma-p-tau

plasma-p-tau

4 studies tagged plasma-p-tau, dated 2021-12-02 to 2025-02-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts 2025-02-01
  2. Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration 2025-01-08
  3. Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials 2023-03-06

Studies

4 studies carry this tag.

Date range

2021 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 3
  • Neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-02-01 Biomarkers

    Severity of cognitive impairment and race both influence plasma p-Tau 217 levels beyond race-associated differences in CSF p-Tau 181 .

  2. Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-01-08 Biomarkers

    Plasma p-tau 217 and the NfL/p-tau 217 ratio are promising non-invasive biomarkers for differentiating AD from FTLD, suggesting their use as a potential alternative to traditional diagnostic methods.

  3. Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. Neurology 2023-03-06 Biomarkers

    Plasma p-tau181/NfL can potentially be used to monitor large-scale population interventions in CU individuals.

  4. Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-12-02 Biomarkers

    These results support plasma p-tau 181 for the detection of AD dementia and the use of blood-based biomarkers for optimal disease detection.

All topic tags with their study counts